Voicu Ciobanu, MD

Professor

Education:
  • MD – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Residency – Diabetes, Obesity, Nutritional and Metabolic Diseases, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Biography:

Voicu S. Ciobanu, MD joined 蜜桃社区 University as Professor of Basic Sciences in November 2024. Passionate about teaching Pathology, applications of AI and digital image analysis in medical education and in cancer research, Dr. Ciobanu dedicates his three decades of experience to the success of students and their medical career advancement. Previously Dr. Ciobanu taught Pathology at Noorda College of Osteopathic Medicine. As a founding faculty of this new school Dr. Ciobanu designed, created and integrated Pathology content using a student-centric approach with a focus on multi-disciplinary integration.

As clinical researcher at University of California Los Angeles (UCLA), Dr. Ciobanu was involved in several National Institutes of Health (NIH) studies of diabetes and diabetic complications: Diabetes Prevention Program (DPP) for type 2 diabetic patients, Family Investigation of Nephropathy in Diabetes (FIND), Insulin Resistance Atherosclerosis Study (IRAS).

As principal investigator and co-investigator for several NIH funded studies at University of Southern California Dr. Ciobanu studied genetics of Systemic Lupus Erythematosus (SLE) and is the author of a genetic analysis expert system that enabled a genome wide scan for SLE markers.

For more than a decade, in Surgical Pathology, Dr. Ciobanu was involved in cancer research, procurement of cancer tissue samples for a Bio-Bank repository, and trained pathology residents, fellows and allied personnel in the research specific tissue procurement requirements. Also Dr. Ciobanu was actively involved in digital image scanning, analysis and AI applications research.

Teaching Areas:
  • Pathology
  • Pathophysiology
Research Interests:
  • Artificial Intelligence applications in pathology and medical education
  • Digital imaging and digital image analysis in pathology
  • Tumor banking and cancer research
  • Diabetes and diabetes complications
Service to Profession:
  • Reviewer, Medical Science Educator, 2021-Present
  • Member, International Association of Medical Science Educators, 2021-Present
  • Member, American Medical Association, 2010-Present
Service to Community:
  • CARE Award, Pathology Department of UCLA, 2015
  • Merit award Noorda COM, 2022, 2023
  • Volunteer Outstanding Service Award, Elmhurst Hospital Center, 2009
Select Peer-Reviewed Publications:
  1. Antoni Ribas, Paul Tumeh, Christina Harview, Jennifer Yearly, I. Peter Shintaku, Emma Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu, Alisha West, Manuel Carmona, Christine Kivork, Elizabeth Seja, Grace Cherry, Antonio Gutierrez, Tristan Grogan, Christine Mateus, Gorana Tomasic, John Glaspy, Ryan Emerson, Harlan Robins, Robert Pierce, David Elashoff, and Caroline Robert. “PD-1 blockade induces responses by inhibiting adaptive immune resistance”. Nature 515(7528):568-571. 2014 Nov 27; PMID 25428505.
  2. Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP Jr, Reiff A, Myones BL, Guthridge JM, Nath SK, Bruner GR, Mehrian-Shai R, Silverman E, KleinGitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Putterman C, Bae SC, Kim YJ, Petri M, Reveille JD, Vyse TJ, Gilkeson GS, Kamen DL, Alarc贸nRiquelme ME, Gaffney PM, Moser KL, Merrill JT, Scofield RH, James JA, Langefeld CD, Harley JB, Jacob CO. 鈥淗igh-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.鈥� Arthritis Rheum 60(4):1085-95. 2009 Apr; PMID: 19333953
  3. Diabetes Prevention Program Research Group. 鈥淪trategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program鈥�. Diabetes Care. 28(1):138-44. 2005 Jan. PMID: 15616247
  4. Diabetes Prevention Program Research Group. 鈥淒ietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization鈥�. Ann Epidemiol. 14(10):763-72. 2004 Nov. PMID: 15573453
  5. Diabetes Prevention Program Research Group. 鈥淲ithin-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes鈥�. Diabetes Care. 26(9):2518-23. 2003 Sep. PMID: 12941712
  6. Jacob CO. Zang S. Li L. Ciobanu V. Quismorio F. Mizutani A. Satoh M. Koss M. 鈥淧ivotal role of stat4 and stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice鈥�. Journal of Immunology. 171(3): 1564-71, 2003 Aug. PMID: 12874250
    1.
  7. Diabetes Prevention Program Research Group. 鈥淭he Diabetes Prevention Program and its global implications鈥�. Journal of the American Society of Nephrology. 14 (7 Suppl 2):S103-7, 2003 Jul. PMID: 12819312
  8. Diabetes Prevention Program Research Group. 鈥淓ffects of withdrawal from Metformin on the development of diabetes in the diabetes prevention program鈥�. Diabetes Care. 26(4):977-80. 2003 Apr. PMID: 12663559
  9. Diabetes Prevention Program Research Group. 鈥淒iet and exercise in the prevention of diabetes鈥�. International Journal of Clinical Practice. Supplement. (134): 28-35, 2003 Mar. Review. PMID: 12793595
  10. Diabetes Prevention Program Research Group. 鈥淩eduction in the Incidence of Type II Diabetes with Lifestyle Intervention or Metformin鈥�, The New England Journal of Medicine, vol. 346(6): 393-403, Feb. 7, 2002. PMID: 11832527

 

Last updated: 03/17/2025